Cerevel Therapeutics Holdings, Inc. Cash on Hand 2021-2024 | CERE
Cerevel Therapeutics Holdings, Inc. cash on hand from 2021 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Cerevel Therapeutics Holdings, Inc. Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $991 |
| 2022 | $892 |
| 2021 | $566 |
| 2020 | $384 |
| 2019 | $80 |
| 2018 | $95 |
| Cerevel Therapeutics Holdings, Inc. Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $846 |
| 2023-12-31 | $991 |
| 2023-09-30 | $677 |
| 2023-06-30 | $736 |
| 2023-03-31 | $827 |
| 2022-12-31 | $892 |
| 2022-09-30 | $990 |
| 2022-06-30 | $531 |
| 2022-03-31 | $543 |
| 2021-12-31 | $566 |
| 2021-09-30 | $670 |
| 2021-06-30 | $327 |
| 2021-03-31 | $343 |
| 2020-12-31 | $384 |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2020-03-31 | |
